| Systems biology approaches to investigating the roles of extracellular vesicles in human diseases A Gézsi, Á Kovács, T Visnovitz, EI Buzás Experimental & molecular medicine 51 (3), 1-11, 2019 | 73 | 2019 |
| Evaluation of a partial genome screening of two asthma susceptibility regions using bayesian network based bayesian multilevel analysis of relevance I Ungvári, G Hullám, P Antal, PS Kiszel, A Gézsi, É Hadadi, V Virág, ... PLoS One 7 (3), e33573, 2012 | 65 | 2012 |
| Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance O Lautner-Csorba, A Gézsi, ÁF Semsei, P Antal, DJ Erdélyi, G Schermann, ... BMC medical genomics 5, 1-15, 2012 | 62 | 2012 |
| Mitochondrial dysfunction and autism: comprehensive genetic analyses of children with autism and mtDNA deletion NÁ Varga, K Pentelényi, P Balicza, A Gézsi, V Reményi, V Hársfalvi, ... Behavioral and Brain Functions 14, 1-14, 2018 | 58 | 2018 |
| Roles of genetic polymorphisms in the folate pathway in childhood acute lymphoblastic leukemia evaluated by Bayesian relevance and effect size analysis O Lautner-Csorba, A Gezsi, DJ Erdelyi, G Hullam, P Antal, AF Semsei, ... PloS one 8 (8), e69843, 2013 | 56 | 2013 |
| Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma M Hegyi, A Arany, AF Semsei, K Csordas, O Eipel, A Gezsi, N Kutszegi, ... Oncotarget 8 (6), 9388, 2016 | 47 | 2016 |
| Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma JC Sági, B Egyed, A Kelemen, N Kutszegi, M Hegyi, A Gézsi, ... BMC cancer 18, 1-14, 2018 | 46 | 2018 |
| HLA-DRB1* 07: 01–HLA-DQA1* 02: 01–HLA-DQB1* 02: 02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia N Kutszegi, X Yang, A Gézsi, G Schermann, DJ Erdélyi, ÁF Semsei, ... haematologica 102 (9), 1578, 2017 | 42 | 2017 |
| Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia A Rzepiel, N Kutszegi, A Gézsi, JC Sági, B Egyed, G Péter, H Butz, ... Journal of translational medicine 17, 1-16, 2019 | 33 | 2019 |
| VariantMetaCaller: automated fusion of variant calling pipelines for quantitative, precision-based filtering A Gézsi, B Bolgár, P Marx, P Sarkozy, C Szalai, P Antal BMC genomics 16, 1-15, 2015 | 33 | 2015 |
| Accelerated clearance alone explains ultra‐large multimers in von Willebrand disease Vicenza A Gézsi, U Budde, I Deák, E Nagy, A Mohl, Á Schlammadinger, Z Boda, ... Journal of Thrombosis and Haemostasis 8 (6), 1273-1280, 2010 | 30 | 2010 |
| MicroRNA-181a as novel liquid biopsy marker of central nervous system involvement in pediatric acute lymphoblastic leukemia B Egyed, N Kutszegi, JC Sági, A Gézsi, A Rzepiel, T Visnovitz, P Lőrincz, ... Journal of Translational Medicine 18, 1-12, 2020 | 29 | 2020 |
| Learning Complex Bayesian Network Features for Classification. P Antal, A Gézsi, G Hullám, A Millinghoffer Probabilistic Graphical Models, 9-16, 2006 | 28 | 2006 |
| Shared extracellular vesicle miRNA profiles of matched ductal pancreatic adenocarcinoma organoids and blood plasma samples show the power of organoid technology A Zeöld, GO Sándor, A Kiss, AÁ Soós, T Tölgyes, A Bursics, Á Szűcs, ... Cellular and Molecular Life Sciences 78, 3005-3020, 2021 | 26 | 2021 |
| Investigation of the possible role of the Hippo/YAP1 pathway in asthma and allergy LE Fodor, A Gézsi, ldikó Ungvári, ÁF Semsei, Z Gál, A Nagy, G Gálffy, ... Allergy, Asthma & Immunology Research 9 (3), 247-256, 2017 | 25 | 2017 |
| NKX2-1 new mutation associated with myoclonus, dystonia, and pituitary involvement P Balicza, Z Grosz, V Molnár, A Illés, D Csabán, A Gézsi, L Dézsi, ... Frontiers in Genetics 9, 335, 2018 | 24 | 2018 |
| Investigation of circulating lncRNAs as potential biomarkers in chronic respiratory diseases Z Gál, A Gézsi, ÁF Semsei, A Nagy, M Sultész, Z Csoma, L Tamási, ... Journal of translational medicine 18, 1-15, 2020 | 23 | 2020 |
| Efficacy of vemurafenib treatment in 43 metastatic melanoma patients with BRAF mutation. Single-institute retrospective analysis, early real-life survival data K Czirbesz, E Gorka, T Balatoni, G Panczel, K Melegh, P Kovacs, A Gezsi, ... Pathology & Oncology Research 25, 45-50, 2019 | 23 | 2019 |
| Pharmacogenetics of anthracyclines JC Sági, N Kutszegi, A Kelemen, LE Fodor, A Gézsi, GT Kovács, ... Pharmacogenomics 17 (9), 1075-1087, 2016 | 22 | 2016 |
| Comprehensive analysis of rare variants of 101 autism-linked genes in a Hungarian cohort of autism spectrum disorder patients P Balicza, NÁ Varga, B Bolgár, K Pentelényi, R Bencsik, A Gál, A Gézsi, ... Frontiers in genetics 10, 434, 2019 | 21 | 2019 |
Peter AntalAssociate professor, Budapest University of Technology and EconomicsEmail verificata su mit.bme.hu
